Semaglutide Weight Loss in Michigan
Medically supervised GLP-1 therapy with a double board-certified physician and PA-C. Individualized dosing protocols that produce real, lasting results — not just a prescription.
A GLP-1 medication that resets how your body manages weight
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist — a class of medication originally developed for Type 2 diabetes that researchers discovered produces significant, sustained weight loss.
Brand names include Wegovy® (FDA-approved for weight loss) and Ozempic® (FDA-approved for Type 2 diabetes). Compounded semaglutide is also available through MWLI-affiliated licensed pharmacies when medically appropriate.
Unlike stimulant-based weight loss medications, semaglutide works by mimicking a hormone your gut already produces — signaling fullness, slowing gastric emptying, and reducing appetite-driving signals in the brain.
How Semaglutide Works
GLP-1 Receptor Activation
Semaglutide binds to GLP-1 receptors in the pancreas, gut, and brain — the same receptors activated by natural hunger and satiety hormones.
Appetite Suppression
Signals in the hypothalamus reduce food cravings and caloric drive — patients report eating less without feeling deprived.
Slower Gastric Emptying
Food moves more slowly from the stomach to the small intestine, prolonging the sensation of fullness after meals.
Gradual Dose Escalation
MWLI physicians titrate dose slowly — typically over 16–20 weeks — to minimize side effects while maximizing fat loss.
What the research shows
Semaglutide has more high-quality clinical data behind it than any weight-loss medication in history. Here's what the landmark STEP trials found.
Individual results vary. Clinical trial results reflect outcomes in controlled research settings with lifestyle support. MWLI programs include nutritional guidance and behavioral coaching to support optimal outcomes.
Who qualifies for semaglutide at MWLI?
Your MWLI physician will conduct a full medical evaluation. General criteria follow FDA labeling and clinical guidelines.
- BMI of 30 or higher (obesity)
- BMI of 27 or higher with at least one weight-related condition (hypertension, high cholesterol, sleep apnea, Type 2 diabetes, or cardiovascular disease)
- Prior difficulty maintaining weight loss through diet and exercise alone
- No contraindicated medical history (reviewed at consultation)
- Commitment to regular monitoring and follow-up visits
- Personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Prior serious hypersensitivity reaction to semaglutide or excipients
- Current pregnancy or active breastfeeding
- Certain pancreatic conditions (evaluated at consultation)
An MWLI physician will review your full history and recommend the right treatment — whether that's semaglutide, tirzepatide, or another approach.
From consultation to results
Request a Consultation
Meet with an MWLI physician to review your health history, goals, and medication options. Consultations are billed to insurance.
Medical Evaluation
Lab work, vitals, and a comprehensive metabolic assessment. We verify insurance and benefits at this stage.
Personalized Protocol
Your physician prescribes a titration schedule — starting low and increasing dose every 4 weeks — alongside nutrition and behavior support.
Ongoing Monitoring
Regular follow-up visits track progress, manage any side effects, and adjust your protocol to sustain results long-term.
Semaglutide FAQs
Many patients lose 10-20% of their body weight with semaglutide. However, results vary from person to person. Your weight loss depends on factors like your starting weight, lifestyle habits, dosage, and medical history.
At Michigan Weight Loss Institute, we create personalized treatment plans to support safe and sustainable weight loss.
Insurance coverage for semaglutide varies by plan. Some Michigan insurance plans cover GLP-1 medications for weight loss or diabetes treatment. However, prior authorization is often required.
Our team helps patients verify coverage and explore alternative options when needed.
Common side effects may include nausea, constipation, diarrhea, bloating, reflux, fatigue, or decreased appetite. In most cases, side effects improve over time as your body adjusts to treatment.
Our medical team closely monitors patients throughout the process to improve comfort and safety.
Semaglutide supports long-term weight management and metabolic health. Some patients use it short term. Others benefit from longer treatment plans.
The length of treatment depends on your goals, medical history, and overall progress. Your provider will create a plan that fits your needs.
Michigan Weight Loss Institute may offer FDA-approved brand-name GLP-1 medications as well as compounded semaglutide when appropriate and legally available.
Your treatment recommendation depends on insurance coverage, medication availability, medical history, and treatment goals.
Visit us in Sterling Heights or Bingham Farms
In-person appointments in Sterling Heights and Bingham Farms. Limited telehealth — call us to discuss availability.
In-person & telehealth
